{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:56:00Z","timestamp":1772142960103,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA043204"],"award-info":[{"award-number":["DA043204"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA011792"],"award-info":[{"award-number":["DA011792"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA016179"],"award-info":[{"award-number":["AA016179"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00213-019-05447-1","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T13:02:57Z","timestamp":1578747777000},"page":"1183-1194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tolerance and dependence following chronic alprazolam treatment: quantitative observation studies in female rhesus monkeys"],"prefix":"10.1007","volume":"237","author":[{"given":"Angela N.","family":"Duke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-5017","authenticated-orcid":false,"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"5447_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11920-016-0727-9","volume":"89","author":"G Airagnes","year":"2016","unstructured":"Airagnes G, Pelissolo A, Lavall\u00e9e M, Flament M, Limosin F (2016) Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep 89:89. https:\/\/doi.org\/10.1007\/s11920-016-0727-9","journal-title":"Curr Psychiatry Rep"},{"key":"5447_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1124\/jpet.109.158303","volume":"332","author":"NA Ator","year":"2010","unstructured":"Ator NA, Atack JR, Hargreaves RJ, Burns HD, Dawson GR (2010) Reducing abuse liability of GABAA\/benzodiazepine ligands via selective partial agonist efficacy at \u03b11 and \u03b12\/3 subtypes. J Pharmacol Exp Ther 332:4\u201316","journal-title":"J Pharmacol Exp Ther"},{"key":"5447_CR3","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1038\/npp.2016.49","volume":"41","author":"LM Behlke","year":"2016","unstructured":"Behlke LM, Foster RA, Liu J, Benke D, Benham RS, Nathanson AJ, Yee BK, Zeilhofer HU, Engin E, Rudolph U (2016) A pharmacogenetic \u2018restriction-of-function\u2019 approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing GABAA receptors in mice. Neuropsychopharmacology 41:2492\u20132501","journal-title":"Neuropsychopharmacology"},{"key":"5447_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0893-133X(94)00074-A","volume":"12","author":"DS Cowley","year":"1995","unstructured":"Cowley DS, Roy-Burne PP, Radant A, Ritchie JC, Greenblatt DJ, Nemeroff CB, Hommer DW (1995) Benzodiazepine sensitivity in panic disorder: effects of chronic alprazolam treatment. Neuropsychopharmacology 12:147\u2013157","journal-title":"Neuropsychopharmacology"},{"key":"5447_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1124\/jpet.118.249250","volume":"366","author":"AN Duke","year":"2018","unstructured":"Duke AN, Meng Z, Platt DM, Atack JR, Dawson GR, Reynolds DS, Tiruveedhula VVNPB, Li G, Stephen MR, Sieghart W, Cook JM, Rowlett JK (2018) Evidence that sedative effects of benzodiazepines involve unexpected GABAA receptor subtypes: quantitative observation studies in rhesus monkeys. J Pharmacol Exp Ther 366:145\u2013157","journal-title":"J Pharmacol Exp Ther"},{"key":"5447_CR6","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/0006-8993(96)00644-0","volume":"734","author":"C Fernandes","year":"1996","unstructured":"Fernandes C, File SE, Berry D (1996) Evidence against oppositional and pharmacokinetic mechanisms of tolerance to diazepam\u2019s sedative effects. Brain Res 734:236\u2013242","journal-title":"Brain Res"},{"key":"5447_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2015.09.038","volume":"310","author":"MC Ferreri","year":"2015","unstructured":"Ferreri MC, Gutierrez ML, Gravielle MC (2015) Tolerance to the sedative and anxiolytic effects of diazepam is associated with different alterations of GABAA receptors in rat cerebral cortex. Neuroscience 310:152\u2013162","journal-title":"Neuroscience"},{"key":"5447_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00213-013-2975-2","volume":"227","author":"BD Fischer","year":"2013","unstructured":"Fischer BD, Teixeira LP, van Linn ML, Namjoshi OA, Cook JM, Rowlett JK (2013) Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation. Psychopharmacology 227:347\u2013354","journal-title":"Psychopharmacology"},{"key":"5447_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.phrs.2015.12.030","volume":"109","author":"MC Gravielle","year":"2016","unstructured":"Gravielle MC (2016) Activation-induced regulation of GABAA receptors: is there a link with the molecular basis of benzodiazepine tolerance? Pharmacol Res 109:92\u2013100","journal-title":"Pharmacol Res"},{"key":"5447_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0378-4347(00)82163-5","volume":"534","author":"DJ Greenblatt","year":"1990","unstructured":"Greenblatt DJ, Javaid JI, Lockniskar A, Harmatz JS, Shader RI (1990) Gas chromatographic analysis of alprazolam in plasma: replicability, stability and specificity. J Chromatogr 534:202\u2013207","journal-title":"J Chromatogr"},{"key":"5447_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130050422","volume":"134","author":"RR Griffiths","year":"1997","unstructured":"Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals \u2013 implications for problems of long-term use and abuse. Psychopharmacology 134:1\u201337","journal-title":"Psychopharmacology"},{"key":"5447_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0376-8716(84)90013-9","volume":"14","author":"RJ Lamb","year":"1984","unstructured":"Lamb RJ, Griffiths RR (1984) Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896. Drug Alcohol Depend 14:11\u201317","journal-title":"Drug Alcohol Depend"},{"key":"5447_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","volume":"90","author":"SC Licata","year":"2008","unstructured":"Licata SC, Rowlett JK (2008) Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond. Pharmacol Biochem Behav 90:74\u201389","journal-title":"Pharmacol Biochem Behav"},{"key":"5447_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1126\/science.6287579","volume":"217","author":"SE Lukas","year":"1982","unstructured":"Lukas SE, Griffiths RR (1982) Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science 217:1161\u20131163","journal-title":"Science"},{"key":"5447_CR15","doi-asserted-by":"publisher","unstructured":"Meng Z, Berro LF, Sawyer EK, R\u00fcedi-Bettschen D, Cook JE, Li G, Platt DM, Cook JM, Rowlett JK (2019) Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for\u2009\u03b13 subunit-containing GABAA receptors. J Psychopharmacol in press, available online. https:\/\/doi.org\/10.1177\/0269881119882803","DOI":"10.1177\/0269881119882803"},{"key":"5447_CR16","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1124\/jpet.105.094474","volume":"316","author":"NO Mirza","year":"2006","unstructured":"Mirza NO, Nielsen E\u00d8 (2006) Do subtype-selective \u03b3-aminobutyric acidA receptor modulators have a reduced propensity to induce physical dependence in mice? J Pharmacol Exp Ther 316:1378\u20131385","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"5447_CR17","first-page":"28","volume":"66","author":"CP O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CP (2005) Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66(Suppl 2):28\u201333","journal-title":"J Clin Psychiatry"},{"key":"5447_CR18","doi-asserted-by":"publisher","first-page":"10.5.1","DOI":"10.1002\/0471141755.ph1005s56","volume":"56","author":"DM Platt","year":"2011","unstructured":"Platt DM, Carey G, Spealman RD (2011) Models of neurological disease (substance abuse): self-administration in monkeys. Curr Protoc Pharmacol 56:10.5.1\u201310.5.17","journal-title":"Curr Protoc Pharmacol"},{"key":"5447_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","volume":"33","author":"P Skolnick","year":"2012","unstructured":"Skolnick P (2012) Anxioselective anxiolytics: on a quest for the holy grail. Trends Pharmacol Sci 33:611\u2013620","journal-title":"Trends Pharmacol Sci"},{"key":"5447_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/BF00180845","volume":"88","author":"RD Spealman","year":"1986","unstructured":"Spealman RD (1986) Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines. Psychopharmacology 88:398\u2013400","journal-title":"Psychopharmacology"},{"key":"5447_CR21","unstructured":"Substance Abuse and Mental Health Services Administration (2013) Drug abuse warning network, 2011: national estimates of drug-related emergency department visits. HHS Publication No. (SMA) 13-4760, DAWN Series D-39. Rockville, MD: Substance Abuse and Mental Health Services Administration"},{"key":"5447_CR22","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1523\/JNEUROSCI.1067-04.2004","volume":"24","author":"C van Rijnsoever","year":"2004","unstructured":"van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, M\u00f6hler H, Fritschy JM, Crestani F (2004) Requirement of \u03b15-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 24:6785\u20136790","journal-title":"J Neurosci"},{"key":"5447_CR23","doi-asserted-by":"publisher","first-page":"e43054","DOI":"10.1371\/journal.pone.0043054","volume":"7","author":"CH Vinkers","year":"2012","unstructured":"Vinkers CH, van Oorschot R, Nielsen EO, Cook JM, Hansen HH, Groenink L, Olivier B, Mirza NR (2012) GABAA receptor a subunits differentially contribute to diazepam tolerance after chronic treatment. PLoS One 7:e43054","journal-title":"PLoS One"},{"key":"5447_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","volume":"5","author":"KA Wafford","year":"2005","unstructured":"Wafford KA (2005) GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence? Curr Opin Pharmacol 5:47\u201352","journal-title":"Curr Opin Pharmacol"},{"key":"5447_CR25","first-page":"41","volume":"285","author":"EM Weerts","year":"1998","unstructured":"Weerts EM, Ator NA, Grech DM, Griffiths RR (1998) Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons. J Pharmacol Exp Ther 285:41\u201353","journal-title":"J Pharmacol Exp Ther"},{"key":"5447_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2005.06.038","volume":"519","author":"EM Weerts","year":"2005","unstructured":"Weerts EM, Ator NA, Kaminski BJ, Griffiths RR (2005) Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons. Eur J Pharmacol 519:103\u2013113","journal-title":"Eur J Pharmacol"},{"key":"5447_CR27","first-page":"307","volume":"185","author":"T Yanagita","year":"1973","unstructured":"Yanagita T, Takahashi S (1973) Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185:307\u2013316","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05447-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05447-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05447-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T01:31:08Z","timestamp":1610242268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05447-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5447"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05447-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,11]]},"assertion":[{"value":"20 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research protocols were approved by the Institutional Animal Care and Use Committee at Harvard Medical School.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}